Point-Of-Sale Rebates In Part D Could Save Seniors $20bn, PhRMA Argues
Executive Summary
PhRMA President Ubl discusses drug pricing advocacy priorities in Medicare Part D during media briefing.
You may also be interested in...
CVS Medicare Part D Plan With Pass-Through Rebates Has Limited Uptake
Low enrollment indicates that beneficiaries have trouble figuring out whether reductions in cost sharing would offset a much higher premium.
Beyond Rebates: PhRMA Wants HHS To ‘De-Link’ Supply Chain Compensation From List Price
Focus should not be limited to rebates in Medicare Part D, manufacturers advise in comments on HHS drug pricing blueprint. Pharmacy benefit managers raise anti-trust issues with shift to upfront discounts.
Beyond Rebates: PhRMA Wants HHS To ‘De-Link’ Supply Chain Compensation From List Price
Focus should not be limited to rebates in Medicare Part D, manufacturers advise in comments on HHS drug pricing blueprint. Pharmacy benefit managers raise anti-trust issues with shift to upfront discounts.